| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.00012 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -5.7e-05 | 1 |